TGT
44
9
VLO
26
3
GIS
35
-12
REGN
44
2
O
20
-6
LLY
45
8
DVA
65
3
M
46
6
MA
62
2
MTCH
71
9
EQT
50
3
NAVI
33
-8
MSI
54
2
KLAC
56
11
CCI
20
-11
SLB
44
3
MCHP
36
3
R
59
4
BSX
67
3
NWSA
71
2
TGT
44
9
VLO
26
3
GIS
35
-12
REGN
44
2
O
20
-6
LLY
45
8
DVA
65
3
M
46
6
MA
62
2
MTCH
71
9
EQT
50
3
NAVI
33
-8
MSI
54
2
KLAC
56
11
CCI
20
-11
SLB
44
3
MCHP
36
3
R
59
4
BSX
67
3
NWSA
71
2
Financhill
Back

Arbutus Biopharma 10K Form

Sell
29

ABUS
Arbutus Biopharma

Last Price:
$3.18
Seasonality Move:
21.65%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-11-07 10Q ABUS/Arbutus Biopharma Quarterly
2023-08-03 10Q ABUS/Arbutus Biopharma Quarterly
2023-05-04 10Q ABUS/Arbutus Biopharma Quarterly
2022-11-09 10Q ABUS/Arbutus Biopharma Quarterly
2022-08-04 10Q ABUS/Arbutus Biopharma Quarterly
2022-05-05 10Q ABUS/Arbutus Biopharma Quarterly

Receive ABUS News And Ratings

See the #1 stock for the next 7 days that we like better than ABUS

ABUS Financial Statistics

Sales & Book Value

Annual Sales: $18.1M
Cash Flow: $-20.7M
Price / Cash Flow: 0
Annual Sales: $0.56
Price / Book: 5.66

Profitability

EPS (TTM): -0.43000
Net Income (TTM): $-76.7M
Gross Margin: $-40.6M
Return on Equity: -67.36%
Return on Assets: -50.88%

Arbutus Biopharma Earnings Forecast

Key Arbutus Biopharma Financial Ratios

  • The Gross Profit Margin over the past 12 years for ABUS is -586.78%.
  • The Selling, General & Administrative Expenses for ABUS have been equal to 123.89% of Gross Profit Margin.
  • The Research & Development expenses have been 406.26% of Revenue.
  • The Interest Expense is -0.63% of Operating Income.
  • The Net Earning history of ABUS is -401.57% of Total Revenues.
  • Per Share Earnings over the last 26 years have been positive in 16 years.

Arbutus Biopharma Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ABUS
CUSIP: 03879J
Website: arbutusbio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 7.02
Quick Ratio: 6.84

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ABUS Technical Analysis vs Fundamental Analysis

Sell
29
Arbutus Biopharma (ABUS) is a Sell

Is Arbutus Biopharma a Buy or a Sell?

  • Arbutus Biopharma stock is rated a Sell
    The current Arbutus Biopharma [ABUS] share price is $3.19. The Score for ABUS is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.